<DOC>
	<DOCNO>NCT01924182</DOCNO>
	<brief_summary>This study compare two different way treat pain . The two way : 1. continue take current pain medication ( ) 2. receive morphine , pain medication drug pump ( system deliver drug body ) implant . None procedures product use study experimental . The length study 25 week ( 5½ 6½ month ) . The purpose study compare pain opioid side effect people get drug pump people get drug pump stay current pain medication treatment .</brief_summary>
	<brief_title>Intrathecal Morphine Compared Conventional Medical Management Pain Control Opioid-related Side Effects</brief_title>
	<detailed_description>This randomize , control , open-label , multi-center , prospective post-market study assess pain control opioid-related side effect follow route delivery change low dose IT morphine therapy systemic opioid therapy . Subjects nonmalignant , chronic , intractable pain experience inadequate pain relief and/or intolerable side effect systemic opioid therapy receive ≤300 mg/day morphine equivalent dose eligible screening . Additionally , subject know history sleep apnea candidate IT morphine administration via SynchroMed Infusion System . Subjects must previously undergo intrathecal/epidural trial pump infusion therapy .</detailed_description>
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Morphine</mesh_term>
	<criteria>Signed dated Medtronic/IRB approve Informed Consent Form HIPAA Authorization prior study procedure perform Willing able attend visit comply study protocol Willing able abstain alcohol consumption study duration At least 18 year age Male nonpregnant , nonlactating female Currently receive &lt; /= 300 mg/day morphine equivalent systemic opioids screen Used stable dose opioids ( change type prescribe frequency dose ) 30 day prior Screening document medical history Used chronic systemic opioids least 6 month prior Screening document medical history Per investigator 's medical assessment subject 's medical history , subject is/has : A new candidate chronic intrathecal drug therapy ( include prior intrathecal/epidural trial pump infusion therapy ) A diagnosis nonmalignant , chronic intractable pain document medical history Medically stable able undergo surgery implantation SynchroMed Infusion System Completed psychological evaluation within 6 month prior Screening Psychological health condition , financial , and/or legal concern ( within 3 month prior Screening ) would interfere subject 's ability fulfill requirement protocol per investigator 's opinion A history alcohol abuse illicit drug use within 2 year prior Screening A positive urine test illicit drug Screening ( Exception : If subject physician 's prescription illicit drug ; example , medical marijuana ) Known diagnosis moderate severe sleep apnea . Prescribed Continuous Positive Airway Pressure ( CPAP ) , Adaptive ServoVentilation ( ASV ) therapy oral appliance prescribe treatment moderate severe sleep apnea ( current previous history ) An active malignancy diagnose cancer remission least 1 year prior screen An implanted electrical stimulation device ( ) subject expect require one course study Planned enroll currently enrol another investigational drug investigational medical device study participate investigational drug medical device study within 30 day prior Screening Prior Randomization , subject exclude : Diary meet compliance Mean diaryreported 12hour NPRS &lt; 6 ( 0 10 scale , report 5 day ) Positive urine test alcohol Baseline Negative urine test opioids Baseline Baseline sleep study ( PSG ) SaO2 &lt; =80 % &gt; = 5 consecutive minute , and/or ApneaHypopnea Index ( AHI ) &gt; =15 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>chronic pain</keyword>
	<keyword>inadequate pain relief</keyword>
	<keyword>intolerable side effect</keyword>
</DOC>